Skip to content
Home/Companies/Biotech/Nurix Therapeutics
Nurix Therapeutics

Nurix Therapeutics

Biotech·United States·Active
Entry
–
Hold
–
Status
Active

Who owns Nurix Therapeutics?

Nurix Therapeutics is an American Biotech company, currently owned by General Atlantic.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
General Atlantic
Investor
General Atlantic
General Atlantic Growth Equity Fund · 2024 · Growth

Key facts

HQUnited States
SectorBiotech
Websitewww.nurixtx.com

More from General Atlantic Growth Equity Fund

Other portfolio companies in the same fund.

A Place for Mom
A Place for Mom
Active
Business ServicesUS
Absolute Barbecue
Absolute Barbecue
Active
HospitalityIndia
Adyen
Active
FintechNetherlands
Akero Therapeutics
Akero Therapeutics
Active
BiotechUS
Alkami Technology
Alkami Technology
Active
SaaSUS
Amagi
Amagi
Active
TMTUS

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Ariceum Therapeutics GmbH
Active
Enterprise IrelandGermany

Questions

Who owns Nurix Therapeutics?

Nurix Therapeutics is currently owned by General Atlantic, through General Atlantic Growth Equity Fund.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue